Cited by 35Adipokines, Inflammation, and Metabolic DiseasesCardiovascular, Neuropeptides, and Oxidative Stress ResearchCardiovascular Disease and Adiposity

Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications

Open access
Savoia, Carmine, Volpe, Massimo, Alonzo, Alessandro, Rossi, Chiara, Rubattu, Speranza·2010·Clinical Science

Abstract

Natriuretic peptides are endogenous antagonists of vasoconstrictor and salt- and water-retaining systems in the body's defence against blood pressure elevation and plasma volume expansion, through direct vasodilator, diuretic and natriuretic properties. In addition, natriuretic peptides may play a role in the modulation of the molecular mechanisms involved in metabolic regulation and cardiovascular remodelling. The metabolic syndrome is characterized by visceral obesity, hyperlipidaemia, vascular inflammation and hypertension, which are linked by peripheral insulin resistance. Increased visceral adiposity may contribute to the reduction in the circulating levels of natriuretic peptides. The dysregulation of neurohormonal systems, including the renin–angiotensin and the natriuretic peptide systems, may in turn contribute to the development of insulin resistance in dysmetabolic patients. In obese subjects with the metabolic syndrome, reduced levels of natriuretic peptides may be involved in the development of hypertension, vascular inflammation and cardio vascular remodelling, and this may predispose to the development of cardiovascular disease. The present review summarizes the regulation and function of the natriuretic peptide system in obese patients with the metabolic syndrome and the involvement of altered bioactive levels of natriuretic peptides in the pathophysiology of cardiovascular disease in patients with metabolic abnormalities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/cs20090204

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increases in natriuretic peptides associated with high salt intake and volume loading are diminished in obese compared with lean individuals.

    “Increases in NPs associated with high salt intake and volume loading are also diminished in obese compared with lean individuals90–92.”
  • Levels of natriuretic peptides are inappropriately low in obese subjects, and their release in response to volume loading is impaired.

    “Not only are levels of natriuretic peptides inappropriately low in obese subjects23, but their release in response to volume loading is impaired24.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Savoia, C., Volpe, M., Alonzo, A., Rossi, C., & Rubattu, S.
Affiliations
  • Azienda Ospedaliera Sant'Andrea (IT)
  • Istituto Neurologico Mediterraneo (IT)
Corresponding author
  • Savoia, Carmine
  • Volpe, Massimo
  • Alonzo, Alessandro
  • Rossi, Chiara
  • Rubattu, Speranza
Venue
Clinical Science
Published
2009-11-09
Volume
118
Issue
4
Pages
231-240
ISSN
  • 0143-5221 (ISSN-L)
  • 1470-8736
OpenAlex
W2003498110
Cited by
35
References
113
Citations by year
2024: 1 · 2023: 1 · 2022: 3 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 5
FWCI
0.41
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Clinical Science (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
natriuretic peptides, metabolic syndrome, cardiovascular disease, insulin resistance, visceral obesity, hypertension, vascular inflammation, cardiovascular remodeling, renin-angiotensin system, neurohumoral regulation
MeSH terms
Animals, Cardiovascular Diseases, Humans, Obesity, Metabolic Syndrome, Natriuretic Peptides, Adiposity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review